Girish Satya - 25 Mar 2026 Form 4 Insider Report for Zevia PBC (ZVIA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Mar 2026, 16:23:10 UTC
Prior SEC filing
18 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Carnation Jafari, Attorney-in-Fact for Girish Satya

Key filing fact

Girish Satya filed Form 4 for Zevia PBC (ZVIA) on 27 Mar 2026.

Key facts

  • This page summarizes Girish Satya's Form 4 filing for Zevia PBC (ZVIA).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Mar 2026, 16:23.

Change

  • Previous filing in this sequence was filed on 18 Mar 2025.
  • Current net transaction value: -$49,136.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002013276 Primary reporting owner

Satya Girish

Relationship
Chief Financial Officer
Address
C/O ZEVIA PBC, 15821 VENTURA BLVD., SUITE 145, ENCINO
Signature
/s/ Carnation Jafari, Attorney-in-Fact for Girish Satya
Signature date
27 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ZVIA transaction

Class A Common Stock

Sale

Transaction value
$49,136
Shares
-41,662
Change %
-11%
Price
$1.18
Shares after
327,909
Date
25 Mar 2026
Ownership
Direct
Footnotes
F1, F2
ZVIA transaction

Class A Common Stock

Award

Transaction value
Shares
+453,901
Change %
+138%
Price
$0.000000*
Shares after
781,810
Date
26 Mar 2026
Ownership
Direct
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The transaction reported reflects the sale of shares of Class A Common Stock in satisfaction of the Reporting Person's tax liability in connection with the settlement of 96,671 restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade made by the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average sale price of the Issuer's Class A Common Stock. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.23, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Represents RSUs granted under the Zevia PBC 2021 Equity Incentive Plan (the "2021 Plan"). Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. The RSUs vest in 1/4 increments on each anniversary of March 26, 2026 and are settled within 30 days following each vesting date.

Footnote F4

Includes 696,584 RSUs. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer. 189,314 RSUs began vesting in 1/4 increments on each anniversary of March 11, 2024 and are settled within 30 days following each vesting date. 197,368 RSUs began vesting in 1/4 increments on each anniversary of March 14, 2025 and are settled within 30 days following each vesting date. 453,901 RSUs begin vesting in 1/4 increments on each anniversary of March 26, 2026 and are settled within 30 days following each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .